Lagos, Nigeria – The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert regarding counterfeit Phesgo® 600mg/600mg/10ml injection labelled with batch number C5290S20, falsely stated to be manufactured by Roche S.P.A.
The warning follows a complaint from a Lagos University Teaching Hospital (LUTH-NSIA) doctor about the suspected counterfeit product presented by a patient.
Roche, the Marketing Authorisation Holder (MAH), reviewed the product’s images and confirmed it as counterfeit due to discrepancies, including:
- Non-existent batch number in Roche’s database.
- Language inconsistencies.
- Incorrect tamper evidence labels and missing safety features.
No physical sample was available for chemical analysis.
Product Risks
Counterfeit medicines, like the falsified Phesgo®, pose severe health risks, compromising safety, quality, and effectiveness.
Counterfeit Product Details:
- Product Name: Phesgo® 600mg/600mg/10ml Injection
- Manufacturer (Claimed): Roche S.P.A
- Correct Manufacturer: F. Hoffmann-La Roche Ltd., Switzerland
- Batch No.: C5290S20
- Manufacturing Date: 01/2024
- Expiry Date: 01/2026
Phesgo® is primarily used in breast cancer treatment.
NAFDAC has directed surveillance and mop-up operations to eliminate the counterfeit product from circulation.
Advisory to Healthcare Providers and Consumers
- Obtain medicines from authorized suppliers.
- Verify product authenticity and physical condition.
- Report suspected counterfeit products to NAFDAC via 0800-162-3322, email at sf.alert@nafdac.gov.ng, or the Med-Safety app.
This alert will also be submitted to the WHO Global Surveillance and Monitoring System (GSMS).
Get Faster News Update By Joining Our: WhatsApp Channel
All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without written permission from CONVERSEER. Read our Terms Of Use.
